Cipher Pharmaceuticals Inc.

TSX:CPH Stock Report

Market Cap: CA$327.5m

Cipher Pharmaceuticals Future Growth

Future criteria checks 2/6

Cipher Pharmaceuticals is forecast to grow earnings and revenue by 12.7% and 18.8% per annum respectively. EPS is expected to grow by 13.4% per annum. Return on equity is forecast to be 14.2% in 3 years.

Key information

12.7%

Earnings growth rate

13.4%

EPS growth rate

Pharmaceuticals earnings growth54.3%
Revenue growth rate18.8%
Future return on equity14.2%
Analyst coverage

Low

Last updated08 Nov 2024

Recent future growth updates

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Earnings and Revenue Growth Forecasts

TSX:CPH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20265525N/A352
12/31/20255023N/A263
12/31/20243414N/A183
9/30/20242616-6713N/A
6/30/202422231717N/A
3/31/202422231414N/A
12/31/202321201616N/A
9/30/202321321515N/A
6/30/202320281313N/A
3/31/202320271313N/A
12/31/202221271111N/A
9/30/202222101515N/A
6/30/20222181111N/A
3/31/20222291111N/A
12/31/20212281414N/A
9/30/20212251414N/A
6/30/20212361212N/A
3/31/20212131111N/A
12/31/20202241112N/A
9/30/202021777N/A
6/30/20202231011N/A
3/31/20202341112N/A
12/31/201922378N/A
9/30/201923-168N/A
6/30/201922246N/A
3/31/201923302N/A
12/31/201823118N/A
9/30/2018286713N/A
6/30/2018349N/A18N/A
3/31/20183711N/A19N/A
12/31/20174011N/A13N/A
9/30/2017347N/A11N/A
6/30/2017325N/A9N/A
3/31/2017311N/A10N/A
12/31/2016304N/A11N/A
9/30/2016336N/A8N/A
6/30/2016342N/A7N/A
3/31/2016341N/A7N/A
12/31/2015342N/A8N/A
9/30/2015323N/A12N/A
6/30/20153013N/A16N/A
3/31/20153018N/A19N/A
12/31/20142919N/A25N/A
9/30/20143331N/A23N/A
6/30/20143227N/A18N/A
3/31/20142925N/A15N/A
12/31/20132524N/A7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CPH's forecast earnings growth (12.7% per year) is above the savings rate (2.3%).

Earnings vs Market: CPH's earnings (12.7% per year) are forecast to grow slower than the Canadian market (16.7% per year).

High Growth Earnings: CPH's earnings are forecast to grow, but not significantly.

Revenue vs Market: CPH's revenue (18.8% per year) is forecast to grow faster than the Canadian market (7.2% per year).

High Growth Revenue: CPH's revenue (18.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CPH's Return on Equity is forecast to be low in 3 years time (14.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y